Bridgeway Capital Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Bridgeway Capital Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,100	Closed	-$216K	–	1399
2022 Q1	$216K	Sell	10,100 -300	-3%	-$7.94K	﹤0.01%	1159
2021 Q4	$350K	Hold	10,400	–	–	0.01%	1065
2021 Q3	$268K	Hold	10,400	–	–	0.01%	1172
2021 Q2	$144K	Hold	10,400	–	–	﹤0.01%	1288
2021 Q1	$110K	Hold	10,400	–	–	﹤0.01%	1325
2020 Q4	$84K	Hold	10,400	–	–	﹤0.01%	1277
2020 Q3	$78K	Buy	+10,400	New	+$92.3K	﹤0.01%	1275

Other funds holding OPNT

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Bridgeway Capital Management's OPNT Position: Q2 2022 in Review

Bridgeway Capital Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q2 2022, closing a stake of 10,100 shares — an estimated $216K sold.

Bridgeway Capital Management first reported a position in OPNT in Q3 2020 and held it in 7 quarters. The position peaked at $350K in Q4 2021. 33 funds tracked by Wall St. Rank hold OPNT as of Q2 2022.

Bridgeway Capital Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Bridgeway Capital Management sold 10,100 Opiant Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $216K.
Bridgeway Capital Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Bridgeway Capital Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $350K in Q4 2021.
33 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.